Fig. 4From: Patterns of treatment with everolimus exemestane in hormone receptor-positive HER2-negative metastatic breast cancer in the era of targeted therapya Kaplan-Meier curves for patients receiving everolimus exemestane as second-line treatment, stratified by prior therapy. b Kaplan-Meier curves for patients receiving everolimus and exemestane as third-line treatment, stratified by prior therapyBack to article page